1990
DOI: 10.1111/j.1539-6924.1990.tb01053.x
|View full text |Cite
|
Sign up to set email alerts
|

Two‐Event Model for Carcinogenesis: Biological, Mathematical, and Statistical Considerations

Abstract: A two-mutation model for carcinogenesis is reviewed. General principles in fitting the model to epidemiologic and experimental data are discussed, and some examples are given. A general solution to the model with time-dependent parameters is developed, and its use is illustrated by application to data from an experiment in which rats exposed to radon developed lung tumors.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
143
1

Year Published

1997
1997
2015
2015

Publication Types

Select...
5
5

Relationship

2
8

Authors

Journals

citations
Cited by 260 publications
(145 citation statements)
references
References 40 publications
1
143
1
Order By: Relevance
“…Here, we make the case that neoplastic progression that is initiated by the loss of a tumor suppressor (or "gatekeeper") gene in two rare rate-limiting events necessarily leads to a linearly increasing age-specific incidence above an age that is characteristic for the timescale of neoplastic progression, a behavior that reflects the steadily increasing risk of malignant transformations in premalignant clones whose incidence increases linearly in the target organ. This finding is in contrast with the multistage carcinogenesis model view (alluded to above), claiming a power-law (age) behavior that reflects the number of rate-limiting events in the carcinogenic process (via its power), and with the two-stage clonal expansion model, which assumes that initiation occurs after a single ratelimiting event (22)(23)(24) and does not predict a linearly increasing age-specific incidence except for very young ages.…”
contrasting
confidence: 52%
“…Here, we make the case that neoplastic progression that is initiated by the loss of a tumor suppressor (or "gatekeeper") gene in two rare rate-limiting events necessarily leads to a linearly increasing age-specific incidence above an age that is characteristic for the timescale of neoplastic progression, a behavior that reflects the steadily increasing risk of malignant transformations in premalignant clones whose incidence increases linearly in the target organ. This finding is in contrast with the multistage carcinogenesis model view (alluded to above), claiming a power-law (age) behavior that reflects the number of rate-limiting events in the carcinogenic process (via its power), and with the two-stage clonal expansion model, which assumes that initiation occurs after a single ratelimiting event (22)(23)(24) and does not predict a linearly increasing age-specific incidence except for very young ages.…”
contrasting
confidence: 52%
“…However, it was also realized that a two-stage model with clonal expansion of intermediate cell populations could generate similar age-specific incidence curves (3). These considerations, combined with the idea of recessive oncogenesis first formulated by Knudson (4), led to the two-stage clonal expansion (TSCE) model, which explicitly incorporates clonal expansion as a stochastic process during carcinogenesis (5)(6)(7).…”
mentioning
confidence: 99%
“…The two-stage model of carcinogenesis developed by Moolgavkar and colleagues (Moolgavkar and Venzon 1979, Moolgavkar and Knudson 1981, Moolgavkar et al 1988, Moolgavkar and Luebeck 1990 incorporates cell proliferation and differentiation. Hanayama (2001) presented a model for projecting cancer death rates, viewing the two-stage model on the Lexis diagram.…”
Section: Discussionmentioning
confidence: 99%